SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-160583
Filing Date
2021-05-13
Accepted
2021-05-13 16:41:11
Documents
15
Period of Report
2021-05-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d139813d8k.htm   iXBRL 8-K 26569
2 EX-1.1 d139813dex11.htm EX-1.1 176473
3 EX-5.1 d139813dex51.htm EX-5.1 8849
7 GRAPHIC g139813sdsp4_5.jpg GRAPHIC 13553
  Complete submission text file 0001193125-21-160583.txt   406058

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA reph-20210512.xsd EX-101.SCH 3079
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE reph-20210512_lab.xml EX-101.LAB 18139
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE reph-20210512_pre.xml EX-101.PRE 11414
8 EXTRACTED XBRL INSTANCE DOCUMENT d139813d8k_htm.xml XML 3336
Mailing Address 1 E. UWCHLAN AVE, SUITE 112 EXTON PA 19341
Business Address 1 E. UWCHLAN AVE, SUITE 112 EXTON PA 19341 770-534-8239
Recro Pharma, Inc. (Filer) CIK: 0001588972 (see all company filings)

IRS No.: 261523233 | State of Incorp.: PA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36329 | Film No.: 21920275
SIC: 2834 Pharmaceutical Preparations